ResearcherPeking University First HospitalActive in the last 2 years
Xinxin Liu
Matched on ORCID iD 0000-0001-9568-6436; OpenAlex author ID A5008741846. Sources: OpenAlex.
Their work
- Papers
- 2
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 8
2024: 1 paper · 2025: none · 2026: 1 paper
Papers 2
- Chemotherapy-induced senescence promotes stroma stiffness and antioxidant adaptation to promote chemoresistance in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41467-026-75772-5↗
- Hypoxia-induced epigenetic regulation of miR-485-3p promotes stemness and chemoresistance in pancreatic ductal adenocarcinoma via SLC7A11-mediated ferroptosis. Co-author DOI 10.1038/s41420-024-02035-x↗
Closest collaborators
The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Kai Chen · 2 shared papers, 2024–2026 · strength 0.46
- Paper Chemotherapy-induced senescence promotes stroma stiffness and antioxidant adaptation to promote chemoresistance in panc… DOI 10.1038/s41467-026-75772-5↗
- Paper Hypoxia-induced epigenetic regulation of miR-485-3p promotes stemness and chemoresistance in pancreatic ductal adenocar… DOI 10.1038/s41420-024-02035-x↗
- Yinmo Yang · 2 shared papers, 2024–2026 · strength 0.46
- Paper Chemotherapy-induced senescence promotes stroma stiffness and antioxidant adaptation to promote chemoresistance in panc… DOI 10.1038/s41467-026-75772-5↗
- Paper Hypoxia-induced epigenetic regulation of miR-485-3p promotes stemness and chemoresistance in pancreatic ductal adenocar… DOI 10.1038/s41420-024-02035-x↗
- Xiaodong Tian · 2 shared papers, 2024–2026 · strength 0.46
- Paper Chemotherapy-induced senescence promotes stroma stiffness and antioxidant adaptation to promote chemoresistance in panc… DOI 10.1038/s41467-026-75772-5↗
- Paper Hypoxia-induced epigenetic regulation of miR-485-3p promotes stemness and chemoresistance in pancreatic ductal adenocar… DOI 10.1038/s41420-024-02035-x↗
- Enkui Zhang · 1 shared paper, 2026 · strength 0.26
- Dongqi Li · 1 shared paper, 2024 · strength 0.20
- Yongsu Ma · 1 shared paper, 2024 · strength 0.20
- Weikang Liu · 1 shared paper, 2024 · strength 0.20
- Xiangyu Chu · 1 shared paper, 2024 · strength 0.20
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.